{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"NLS Pharmaceutics Ltd."},"Symbol":{"label":"Symbol","value":"NLSP"},"Address":{"label":"Address","value":"THE CIRCLE 6, ZURICH, 8058, Switzerland"},"Phone":{"label":"Phone","value":"+41 445122150"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.nlspharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alexander C. Zwyer","title":"Chief Executive Officer & Director"},{"name":"Eric Konofal","title":"Chief Scientific Officer"},{"name":"George Apostol","title":"Chief Medical Officer & Head-Global Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}